Read the latest positive news, breakthroughs, and inspiring stories about copd treatment, curated daily by BrightWire.
A respiratory therapy for chronic lung disease reduced emergency care visits while also lowering healthcare emissions by over 25 kg of CO2 per patient annually. The Spanish study shows how better medical treatments can heal both people and the planet.
A breakthrough treatment for chronic lung disease has shown remarkable results, slashing severe breathing attacks by up to 34% regardless of smoking history. The drug, now awaiting FDA review, could transform life for millions living with COPD.
A breakthrough treatment dramatically reduced dangerous breathing episodes in people with COPD, offering new hope for millions who struggle with one of the world's deadliest lung diseases. The therapy worked across all patient types, filling a critical gap in care.
AstraZeneca's experimental COPD drug tozorakimab succeeded in two late-stage trials, reducing severe flare-ups by up to 34% and offering hope to millions who lack treatment options. The once-monthly injection could reach FDA approval by early 2027.
A groundbreaking new medication could help millions of Americans living with COPD breathe easier, with clinical trials showing it cuts severe symptom flare-ups by up to 34%. For the 16 million Americans battling this deadly lung disease, including those who never smoked, this first-of-its-kind treatment offers real hope.
A UCLA study found that environmentally friendly inhalers not only eliminate harmful greenhouse gases but also improve outcomes for people with lung disease. Patients using dry powder inhalers had 14% fewer severe flare-ups than those using traditional inhalers.
Nearly 30,000 people in England with chronic lung disease will gain access to the first treatment that targets an underlying cause, not just symptoms. The twice-monthly injection cuts severe flare-ups by 30% and could save the NHS millions.
A groundbreaking treatment just approved in England could transform life for nearly 30,000 people struggling to breathe with chronic lung disease. The twice-monthly injection is the first to tackle both symptoms and root causes of COPD.
A groundbreaking injection just got approved for NHS use in England and Wales, offering fresh hope to 30,000 people struggling with severe COPD. This marks the first biologic therapy available for uncontrolled chronic lung disease after years of limited innovation.